Adicet Bio Statistics

Total Valuation

Adicet Bio has a market cap or net worth of GBP 58.55 million. The enterprise value is -50.08 million.

Market Cap	58.55M
Enterprise Value	-50.08M

Important Dates

The next estimated earnings date is Monday, March 16, 2026.

Earnings Date	Mar 16, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	9.60M
Shares Outstanding	n/a
Shares Change (YoY)	+95.56%
Shares Change (QoQ)	+88.65%
Owned by Insiders (%)	0.79%
Owned by Institutions (%)	35.99%
Float	6.85M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	0.49
P/TBV Ratio	0.49
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	0.58
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	0.69

Financial Position

The company has a current ratio of 7.47, with a Debt / Equity ratio of 0.09.

Current Ratio	7.47
Quick Ratio	7.38
Debt / Equity	0.09
Debt / EBITDA	n/a
Debt / FCF	-0.15
Interest Coverage	-3,392.06

Financial Efficiency

Return on equity (ROE) is -67.55% and return on invested capital (ROIC) is -40.40%.

Return on Equity (ROE)	-67.55%
Return on Assets (ROA)	-37.00%
Return on Invested Capital (ROIC)	-40.40%
Return on Capital Employed (ROCE)	-71.49%
Weighted Average Cost of Capital (WACC)	11.08%
Revenue Per Employee	n/a
Profits Per Employee	-570,952
Employee Count	152
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -38.98% in the last 52 weeks. The beta is 1.61, so Adicet Bio's price volatility has been higher than the market average.

Beta (5Y)	1.61
52-Week Price Change	-38.98%
50-Day Moving Average	7.68
200-Day Moving Average	10.58
Relative Strength Index (RSI)	51.53
Average Volume (20 Days)	96

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.55

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-90.73M
Pretax Income	-86.78M
Net Income	-86.78M
EBITDA	-85.99M
EBIT	-90.73M
Earnings Per Share (EPS)	-8.08

Full Income Statement

Balance Sheet

The company has 117.79 million in cash and 10.95 million in debt, with a net cash position of 106.84 million.

Cash & Cash Equivalents	117.79M
Total Debt	10.95M
Net Cash	106.84M
Net Cash Per Share	n/a
Equity (Book Value)	118.29M
Book Value Per Share	11.01
Working Capital	103.57M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -70.77 million and capital expenditures -1.29 million, giving a free cash flow of -72.06 million.

Operating Cash Flow	-70.77M
Capital Expenditures	-1.29M
Free Cash Flow	-72.06M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Adicet Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-95.56%
Shareholder Yield	-95.56%
Earnings Yield	-148.23%
FCF Yield	-123.08%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on December 30, 2025. It was a reverse split with a ratio of 0.0625.

Last Split Date	Dec 30, 2025
Split Type	Reverse
Split Ratio	0.0625

Scores

Altman Z-Score	n/a
Piotroski F-Score	1